Viemed Healthcare (VMD) Expected to Announce Quarterly Earnings on Wednesday

Posted by Brian Himes on Oct 28th, 2026

Viemed Healthcare (NASDAQ:VMD – Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Viemed Healthcare to announce earnings of $0.12 per share and revenue of $80.78 million for the quarter. Investors may review the information on the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 11:00 AM ET.

Viemed Healthcare (NASDAQ:VMD – Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). The business had revenue of $78.10 million for the quarter, compared to analysts’ expectations of $78.00 million. On average, analysts expect Viemed Healthcare to post $0.41 EPS for the current fiscal year and $0.54 EPS for the next fiscal year.

Viemed Healthcare Stock Down 0.5%

Viemed Healthcare stock opened at $9.68 on Wednesday. Viemed Healthcare has a 52-week low of $6.05 and a 52-week high of $12.61. The firm has a fifty day moving average of $9.17 and a 200-day moving average of $9.50. The firm has a market capitalization of $368.69 million, a P/E ratio of 26.89 and a beta of 1.04.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on VMD. Weiss Ratings cut shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, August 17th. Freedom Capital lowered Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 5th. Wall Street Zen downgraded Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Finally, Barrington Research began coverage on Viemed Healthcare in a research note on Monday, August 24th. They issued an “outperform” rating and a $14.00 target price for the company. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $14.00.

Get Our Latest Report on VMD

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc (NASDAQ: VMD) is a U.S. healthcare company that provides in-home medical equipment and clinical services for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home while supporting hospitals and clinicians in managing ongoing conditions.

The company’s offerings include non-invasive ventilation, oxygen therapy, sleep-apnea equipment, respiratory therapy, remote patient monitoring and related durable medical equipment.